- McNeil unveils 'Smiling it Forward' campaign in support of Tylenol
- Consumer trust intact as McNeil brands like Tylenol return back to shelf
- FDA recommends health professionals prescribe no more than 325 mg of acetaminophen per dose
- J&J's return to market of several iconic OTC brands a success
- Prestige Brands solution to pediatric overdosing — unique squeezable, single-dose APAP packet
NEW YORK — It seems that Tylenol Cold & Flu Severe caplets are making their way back to store shelves, according to published reports.
According to several reports, McNeil Consumer Healthcare spokeswoman Bonnie Jacobs confirmed that the product, which is designated for adult use, will begin shipping this week.
McNeil Consumer Healthcare, a Johnson & Johnson subsidiary, recalled several lots of Tylenol products due to reports of uncharacteristic odor, which was linked to the presence of trace amounts of a chemical known as 2,4,6-tribromoanisole (TBA).
Back in February, J&J executives said McNeil Consumer’s absence from cough-cold and analgesic aisles, including several pediatric formulations, would extend into the fourth quarter.